SCHEMBL6576258

SCHEMBL6576258

Cc1c(F)c(N2CC(N)C2)c(C)c2c1c(=O)c(C(=O)O)cn2-c1cc(N)c(F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
TOP2A P11388 11/20 0.43
TOP2B Q02880 7/20 0.43
TOP1 P11387 4/20 0.43
KCNH2 Q12809 2/20 0.40
CACNA1F O60840 1/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40
RPS6KB1 P23443 1/20 0.39
MATK P42679 1/20 0.39
DYRK1A Q13627 1/20 0.39
MAPKAPK3 Q16644 1/20 0.39
PIM3 Q86V86 1/20 0.39
AURKB Q96GD4 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20912654 0.90 CYP3A4 (0.41) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7010194 0.88 CACNA1F (0.51) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7014564 0.87 CYP3A4 (0.46) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL6580734 0.87 CYP3A4 (0.56) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL6576283 0.86 TOP1 (0.43) TOP2ATOP2BTOP1KCNH2CACNA1F
SCHEMBL7011812 0.85 KCNH2 (0.47) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7008959 0.85 CYP3A4 (0.58) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL19728826 0.84 CYP3A4 (0.40) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL19729472 0.84 KDM4E (0.37) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL19728827 0.84 CYP3A4 (0.46) CYP3A4CYP2C9TOP2ATOP2BTOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0897919-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2004-06-16 EP disclosed
US-6211375-B1 IMPROVED INTESTINAL ABSORPTION WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2001-04-03 US disclosed
EP-0897919-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-02-24 EP disclosed